BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 30619333)

  • 1. Beyond Killing
    Divangahi M; Khan N; Kaufmann E
    Front Immunol; 2018; 9():2976. PubMed ID: 30619333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting immunometabolism in host defence against Mycobacterium tuberculosis.
    Sheedy FJ; Divangahi M
    Immunology; 2021 Feb; 162(2):145-159. PubMed ID: 33020911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokines in tuberculosis: the good, the bad and the ugly.
    Monin L; Khader SA
    Semin Immunol; 2014 Dec; 26(6):552-8. PubMed ID: 25444549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycobacterial Lipoprotein Z Triggers Efficient Innate and Adaptive Immunity for Protection Against
    Chen Y; Xiao JN; Li Y; Xiao YJ; Xiong YQ; Liu Y; Wang SJ; Ji P; Zhao GP; Shen H; Lu SH; Fan XY; Wang Y
    Front Immunol; 2018; 9():3190. PubMed ID: 30700988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of host and microbial determinants in individuals with latent tuberculosis infection using a human granuloma model.
    Guirado E; Mbawuike U; Keiser TL; Arcos J; Azad AK; Wang SH; Schlesinger LS
    mBio; 2015 Feb; 6(1):e02537-14. PubMed ID: 25691598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired CXCR1-dependent oxidative defence in active tuberculosis patients.
    Alaridah N; Winqvist N; Håkansson G; Tenland E; Rönnholm A; Sturegård E; Björkman P; Godaly G
    Tuberculosis (Edinb); 2015 Dec; 95(6):744-750. PubMed ID: 26316141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-22: An Underestimated Player in Natural Resistance to Tuberculosis?
    Ronacher K; Sinha R; Cestari M
    Front Immunol; 2018; 9():2209. PubMed ID: 30319650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction.
    Kaufmann SH
    Semin Immunol; 2014 Dec; 26(6):429-30. PubMed ID: 25459522
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of mycobacterial bacterioferritin B for immune screening of tuberculosis and latent tuberculosis infection.
    Yang X; Wu JB; Liu Y; Xiong Y; Ji P; Wang SJ; Chen Y; Zhao GP; Lu SH; Wang Y
    Tuberculosis (Edinb); 2017 Dec; 107():119-125. PubMed ID: 29050758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis as a three-act play: A new paradigm for the pathogenesis of pulmonary tuberculosis.
    Hunter RL
    Tuberculosis (Edinb); 2016 Mar; 97():8-17. PubMed ID: 26980490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome wide approaches discover novel Mycobacterium tuberculosis antigens as correlates of infection, disease, immunity and targets for vaccination.
    Coppola M; Ottenhoff TH
    Semin Immunol; 2018 Oct; 39():88-101. PubMed ID: 30327124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immune response to Mycobacterium tuberculosis].
    Nowag A; Hartmann P
    Internist (Berl); 2016 Feb; 57(2):107-16. PubMed ID: 26838368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of CD27 and CCR4 Markers on Specific CD4
    Latorre I; Fernández-Sanmartín MA; Muriel-Moreno B; Villar-Hernández R; Vila S; Souza-Galvão ML; Stojanovic Z; Jiménez-Fuentes MÁ; Centeno C; Ruiz-Manzano J; Millet JP; Molina-Pinargote I; González-Díaz YD; Lacoma A; Luque-Chacón L; Sabriá J; Prat C; Domínguez J
    Front Immunol; 2018; 9():3094. PubMed ID: 30687314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Players in Immunity to Tuberculosis: The Host Microbiome, Lung Epithelium, and Innate Immune Cells.
    Gupta N; Kumar R; Agrawal B
    Front Immunol; 2018; 9():709. PubMed ID: 29692778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycobacterium tuberculosis strain 18b, a useful non-virulent streptomycin dependent mutant to study latent tuberculosis as well as for in vivo and in vitro testing of anti-tuberculosis drugs.
    Campos-Neto A
    Tuberculosis (Edinb); 2016 Jul; 99():54-55. PubMed ID: 27450005
    [No Abstract]   [Full Text] [Related]  

  • 16. Understanding latent tuberculosis: a moving target.
    Lin PL; Flynn JL
    J Immunol; 2010 Jul; 185(1):15-22. PubMed ID: 20562268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterium tuberculosis and the macrophage: maintaining a balance.
    Pieters J
    Cell Host Microbe; 2008 Jun; 3(6):399-407. PubMed ID: 18541216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. At the Interface of Microbiology and Immunology.
    Flynn JL
    J Immunol; 2020 Mar; 204(6):1413-1417. PubMed ID: 32152209
    [No Abstract]   [Full Text] [Related]  

  • 20. The onset of adaptive immunity in the mouse model of tuberculosis and the factors that compromise its expression.
    Robinson RT; Orme IM; Cooper AM
    Immunol Rev; 2015 Mar; 264(1):46-59. PubMed ID: 25703551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.